News
Standard BioTools Inc.’s LAB share price has dipped by 5.28%, which has investors questioning if this is right time to buy.
Researchers in the field of exposomics explain how cutting-edge technologies are unlocking this biological archive, ushering in a new era of disease prevention and personalized medicine.
Every breath we take, every meal we eat, and every environment we encounter leaves a molecular fingerprint in our bodies—a hidden record of our lifelong exposures. In this week's edition of the ...
Parkinson’s disease (PD) is a progressive neurodegenerative disorder, that severely impacts motor and non-motor functions. Early detection and effective ...
By understanding a patient’s unique genetic profile, biomarker readings and lifestyle information, doctors could tailor the ...
Groundbreaking longevity research initiative brings together leading scientists and institutions to decode the genetic basis ...
In a wide-ranging Genomic Press Interview, Dr. Jeremie Poschmann of INSERM and Université de Nantes shares the story behind ...
Key trends include the expansion of virtual biobanking, advancements in cryopreservation technology, and the rise of ...
This necropsy -- an autopsy on an animal -- "is an opportunity to look into the past of our planet", said Artemy Goncharov, ...
Learn about metabolomics, biology's fourth language that has remained vastly untapped up until now and could accelerate ...
Top-down proteomics: Intact proteins are ionized and analyzed directly, allowing for the study of proteoforms and ...
Pioneering dementia research professor Roslyn Bill has welcomed the announcement of a £0.5 million grant for Aston Institute for Membrane Excellence (AIME), saying it will help accelerate her collabo… ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results